Zimulti Acomplia Report - News about the diet drug rimonabant

ZimultiAcompliaReport

Your INDEPENDENT source of news about diet drug Acomplia / Zimulti (Rimonabant)

Neither affiliated with nor endorsed by Sanofi-Aventis

What Is Zimulti / Acomplia / Rimonabant?

Clinical Trials

Side-Effects

What Doctors Say?

When & Where Can I Get It?

Other Diet Drugs

Zimulti / Acomplia & Smoking

	The Zimulti Acomplia Report - 2006 News Archive
	Indexed below are all of the reports that appeared during 2006 on the promising new anti-obesity drug, rimonabant, which will be marketed in Europe as Acomplia and ultimately probably as Zimulti in the United States. The Zimulti Acomplia Report, updated daily, provides the latest news and reviews related to Zimulti / Acomplia so those waiting eagerly for an anti-obesity drug that works with few side effects will have the latest information on development of rimonabant.
	Acomplia News for December 2006 -- News About Rimonabant
	FDA Panel That Would Consider Acomplia Sets Next Meeting for June 2007 Colorado Professor: Long Use of Drugs Like Acomplia May Be 'Disasterous' UK Panel Says Diet Drugs Like Acomplia or Surgery Should Be Last Resort Merck to File for FDA Approval of Rival to Diet Pill Acomplia in 2008 Sanofi: No Action Seen on Diet Pill Acomplia (Rimonabant) Until April 26 Solvay and Bristol-Myers Squibb Move Ahead With Diet Drug Like Acomplia Merck Diet Pill Like Acomplia -- But at Far Lower Dosage -- in Phase III Trial Sanofi Constrained in Promotion of Diabetes Results for Diet Drug Acomplia Diet Drug Acomplia Seen as Significant Help in Control of Diabetes Trial Results to Show Diet Drug Acomplia Can Help Control Type 2 Diabetes
	Acomplia News for November 2006 -- News About Rimonabant
	Pfizer Says Diet Drug in Phase III Trials Could Compete With Acomplia Breathless CBS Report Refers to Acomplia as 'Magic Pill,' and 'Miracle Pill' Leading Acomplia Researcher Has No Idea Why Diet Drug Is Stalled at FDA Psychiatric Disorders in Acomplia Patients Reported to European Regulators FDA Seen Putting Diet Drug Acomplia on Slow Track for Approval Decision Diet Drug Acomplia Goes on Sale in Sweden -- With Insurance Coverage Diet Drug Acomplia (Rimonabant) Approved for Sale in Mexico Reports on Diet Drug Acomplia From British Users May Be Worth Noting More Good News Coming About Diet Pill Acomplia as Type 2 Diabetes Drug
	Acomplia News for October 2006 -- News About Rimonabant
	Sanofi Completes Acomplia Response to FDA, But Offers No Forecast Diet Drug Acomplia Seen Needing More Testing as Diabetes Treatment Sanofi's Moment of Truth on Acomplia and the FDA Could Come Oct. 31 Chinese Reported Arrested for Pushing Drug Too Similar to Acomplia Germany Classifies Acomplia as 'Lifestyle' Drug, Barring Insurance Coverage Old News About Diet Drug Acomplia Is Again Subject of Breathless Report Hopes That Insurers May Pay for Diet Drug Acomplia Get Boost From Aetna Diet Drug Acomplia Still Has No Date With Key FDA Advisory Panel Injectible Type 2 Diabetes Drug Liraglutide to Be Tested as Diet Drug Sanofi Denies FDA Asking for Safety Data From Acomplia Sales in Europe Diet Drug Acomplia (Rimonabant) Now Available in 7 European Countries Sanofi: Diet Drug Acomplia Launch in U.S. Still on Track for 2006 Sanofi Silence on Acomplia Gives Shareholders 'Reason to Be Nervous' Merck Bails on 1 Diet Pill, But Moves Ahead With Drug Similar to Acomplia Acomplia Report Launches Discussion Forum for Diet Drug Users
	Acomplia News for September 2006 -- News About Rimonabant
	Diet Drug Acomplia (Rimonabant) on Sale in 4 Countries, But at What Price? No Word From Sanofi or FDA on Diet Drug Acomplia as Summer Ends Readers Urged to Beware of Mystery Diet Pill Confusingly Named Accomplix Diet Drug Xenical (Orlistat) Aids Glucose Control in Obese Diabetics Diet Pill Xenical (Orlistat) Helps Obese Adolescents Lose Weight Diet Drug Acomplia: Still Not Available in Germany? If Not, Why Not? Sanofi Optimism on Diet Drug Acomplia Takes Hit From New Rebuff by FDA
	Acomplia News for August 2006 -- News About Rimonabant
	Acomplia Seen No Better Than Older Diet Pills in Reducing Bad Cholesterol Sanofi Postpones Diet Pill Acomplia Launch in Germany Until Sept. 1 Diet Drug Acomplia (Rimonabant) to Go on Sale This Week in Germany New Study of Diet Drug PYY3-36 Seeks Optimal Nasal Spray Dose Sanofi Competitors Eager to See Warnings FDA Will Require for Acomplia Safety of Acomplia for Obese Individuals With Mild Depression Questioned U.S. Outlook for Diet Pill Acomplia (Rimonabant) Remains Cloudy Study: Women on Diet Pill Acomplia May Face Risk in Pregnancy Diet Pill Acomplia (Rimonabant) to Be Available in August in Germany
	Acomplia News for July 2006 -- News About Rimonabant
	Sanofi Update on Diet Pill Acomplia Progress at the FDA: August 2nd? Sanofi Website for Diet Pill Acomplia Evasive on Use for Smoking Cessation Sanofi Creates 'Support' Website for Diet Pill Acomplia Users in the U.K. Report on Diet Pill Benefiting Obese Teens May Fuel Acomplia Concerns Study: Diet Drug Acomplia May Have Role in Fighting Breast Cancer Acomplia May Be on Market, But Not Always Easy to Find in UK Pharmacies Update: Acomplia May Prevent Weight Gain Common With Anti-Depressants What Happens When Marijuana Users Take Diet Drug Acomplia? Study: Diet Pill Acomplia May Prevent Weight Gain Tied to Anti-Depressants Link of Obesity and Psychiatric Disorders May Weigh Against Acomplia Use More Euro-Approved Info About Taking Diet Drug Acomplia (Rimonabant) Do 'Wonder Drug' Headlines for Diet Pill Acomplia Help or Hurt Sanofi?
	Acomplia News for June 2006 -- News About Rimonabant
	Price of Diet Drug Acomplia (Rimonabant) Less Than Expected Diet Drug Acomplia Now on Sale for Just Over $100 per Month in Britain Will Diet Drug Acomplia Be Available This Summer in Canada or Mexico? Diet Drug Acomplia Approved in Europe; Diet Pill Will Go on Sale in July Sanofi 'Confident' on Acomplia, But Diet Pill Not on Key FDA Panel's Agenda More Encouraging Acomplia News Presented at Diabetes Scientific Meeting Sanofi Sees 99.9 Percent Likelihood of Approval of Acomplia in Europe Can Americans Get Diet Drug Acomplia From Europe This Summer?
	Acomplia News for May 2006 -- News About Rimonabant
	Sanofi Hopes to Answer All FDA Acomplia Questions "by Summertime" No Early FDA Action on Acomplia Likely as Advisory Panel Drops Meeting Concerns Over Safety of Acomplia Reported Likely to Linger Promising Results Reported in Small Trial for Experimental Diet Pill Qnexa FDA Approves Smoking-Cessation Aid 10 Weeks After Rejecting Acomplia Diet Drug to Be Sold as Acomplia in Europe, and Likely as Zimulti in U.S. Sanofi: Acomplia May Be Available in Britain or Germany as Early as July Acomplia Draws Fresh Burst of Optimism From European-Based Analyst
	Acomplia News for April 2006 -- News About Rimonabant
	Sanofi Appears to Plan to Market Diet Drug Rimonabant Under Two Names Approval of Acomplia for Weight Loss Recommended by European Panel Glaxo Launches Weight-Loss Website Prior to FDA Action on Alli (Xenical) Stock Guru Offers Gloomier View on FDA's Acomplia Timeline Sanofi's Acomplia May Face Early Competition from Similar Merck Drug Consumer Advocates Urge FDA to Pull Xenical (Orlistat) From the Market FDA Finds Low-Dose Xenical 'Approvable' for Over-the-Counter Sale as Alli Sanofi 's Acomplia May Reduce Bariatric Surgery for Morbid Obesity Sanofi Hints It Also Seeks Approval of Acomplia for 'Metabolic Disorders'
	Acomplia News for March 2006 -- News About Rimonabant
	European Commission Warns Fake Acomplia Is Being Sold on Internet Sanofi Provides No Information on Its FDA Meeting on Acomplia Sanofi Update on FDA and Acomplia: March 22nd? Studies: Acomplia Yields Added Benefits Independent of Weight Loss Sanofi Ponders 'Zimulti' as Yet Another Possible Name for Acomplia Hopes for Early FDA Action on Acomplia Dim as FDA Panel Scrubs Meeting Would You Believe 'Celnec' as the New Name for Rimonabant? When Will Sanofi Come Clean on Acomplia and the FDA When Rimonabant Makes It to Market, Will It Still Be Called Acomplia Merck Gives Up on Diet Drug PYY3-36, Cites Disappointing Study Diabetes Drug Byetta Gaining Attention as Weight-Loss Aid Acomplia's Rejection as Smoking-Cessation Aid: What's The Real Story? Report: Sanofi Selectively Disclosed Acomplia News to Favored Analysts
	Acomplia News for February 2006-- News About Rimonabant
	Acomplia May Be Available in Europe or Mexico Before United States Is There Any Basis for Sanofi's Latest Forecast on Acomplia Approval? Sanofi Says No New Weight-Loss Trial Needed for Acomplia Approval News About Future of Acomplia Seen Likely on Friday, Feb. 24th Analyst Speculation on Acomplia Approval Seen Turning Toward 2007 FDA Had Bad News on Acomplia for Sanofi, But How Bad? FDA: Acomplia May Be 'Approvable" for Weight Loss, But No Okay for Now FDA Rejects Acomplia as Smoking Cessation Aid Why Did So Many Getting Acomplia in a Trial Quit Taking It Along the Way? NIH Researcher Urges Longer Look at Acomplia Safety Before Approval Concern Over Acomplia Side Effects Seen Likely to Delay FDA Approval Old Acomplia Results Create New Excitement When Reported in JAMA Indian Pharma Reports Early Progress on Drug That Works Like Acomplia Sanofi: Acomplia Could Be on Market by June 30th With Feb. OK from FDA New Acomplia Trial Announced, But Enrollment Said Amost Completed
	Acomplia News for January 2006-- News About Rimonabant
	Sanofi Expresses Confidence Acomplia Will Be Available in U.S. Soon Researchers See Expected FDA Approval of Alli as Good News for Dieters FDA Advisory Panels Back Over-the-Counter Sale of Low-Dose Xenical FDA Raises Warning Flags on Over-the-Counter Sale of Low-Dose Xenical Article Calls on FDA to Limit Acomplia to Those "Who Need It to Survive" Report: Acomplia Could Be Approved by FDA 'As Early as Next Month' Two New Clinical Trials of Acomplia Now Underway Report: Acomplia Still Must Overcome "Skepticism About Its Side Effects" Decisions Drawing Near on Approval of the Sale of Acomplia
	Acomplia / Zimulti News for Jan. to Dec. 2007 -- Click for 2007 News Archive
	Acomplia / Zimulti News for Jan. to Dec. 2005 -- Click for 2005 News Archive
	Acomplia / Zimulti News for Jan. to Dec. 2004 -- Click for 2004 News Archive

Consumer Ad Alert!

Privacy Policy | Terms and Disclaimers | About the Zimulti Acomplia Report

Contact Us

We subscribe to the HONcode principles of the HON Foundation.

This is an independent news site reporting on rimonabant, a diet drug developed by Sanofi-Aventis Inc., which is marketing it in Europe under the trademarked name Acomplia and in the United States under the trademarked name Zimulti.. Nothing on this site is intended to infringe on that trademark. Nothing on this site is intended as medical advice. The information provided here is for informational purposes only. Always consult a doctor or medical professional with questions you may have regarding a medical condition.

Last Updated: 10/26/2008